Tafamidis improves myocardial longitudinal strain in A97S transthyretin cardiac amyloidosis.

Yuan-Kun Aden WuAn-Li YuMei-Fang ChengLung-Chun LinMing-Jen LeeChia-Hung ChouChia-Tung ShunHsueh-Wen HsuehJimmy Jyh-Ming JuangPing-Huei TsengSiao-Ping LinMao-Yuan SuChi-Chao ChaoSung-Tsang HsiehCheng-Hsuan TsaiYen-Hung Lin

Published in: Therapeutic advances in chronic disease (2024)

Tafamidis significantly improved GLS, and particularly apical and middle LS in A97S ATTR-CM patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
heart failure
cross sectional